Facility Information

ÉPERNON, FRANCE
WORLDWIDE MEDICINES

Facts and Figures

The facility produces pharmaceutical products in two therapeutic classes :
- Cardiovascular
- Antifungal
The pharmaceutical forms produced include :
- Tablets
- Capsules
- Oral suspensions
The Epernon facility started operations in 1960.
In 2003, the facility produced about 55 million packaged units for both domestic and international markets.
Since February 2001, the facility has utilized the continuous innovation (CI) program, which involves all employees at all levels of the organization.

Economic Development

The facility contributes to the local economy through employee wages and benefits.

Environmental Performance

The Epernon facility was ISO14001 certified in September 1999, and since that time all upholding audits have been successful without any observations.
To maintain and develop its E.M.S., in 2000 the facility created a local ISO14001 website, which contains the guidance necessary for the facility to remain in compliance, and provides feedback about the E.M.S. to all employees.

Facility Contact Information

+33-2-3723-5100

(see also UPSA Pain Institute)

Last updated August 1, 2008 . Italicized product names are registered trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Copyright © 1998-2006 Bristol-Myers Squibb Company. Your use of the information on this site is subject to the terms of our Legal Notices.

Facility Information:

Facts and Figures

Economic Development

Community and Social Progress

Environmental Performance

Facility Contact Information

Return to List of Facilities